Zymeworks Inc. Common Stock (NASDAQ: ZYME) last traded at $25.79, up 2.10% on the session. The quote above updates while this page is open; the figures below are drawn from Zymeworks Inc. Common Stock’s own filings and are restated only when a new one is published.
Zymeworks Inc. Common Stock trades on NASDAQ under the ticker ZYME. Its market capitalisation is $1.83 billion.
Valuation measures for Zymeworks Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.83B |
|---|---|
| Enterprise value | $1.97B |
| Price / sales | 49.29 |
| Price / book | 22.77 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Zymeworks Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $37.13M |
|---|---|
| Net income (TTM) | -$149.99M |
| EPS (TTM) | -$2.02 |
| Operating margin | -418.99% |
| Return on equity | -186.63% |
| Cash | $179.41M |
Range and volume for ZYME over the past 52 weeks.
| 52-week high | $31.34 |
|---|---|
| 52-week low | $16.00 |
| Volume | 491.1K |
| Average volume | 696.7K |
| Previous close | $25.26 |
Invest a chosen dollar amount in Zymeworks Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ZYME.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.